News

Search Articles

1 - 15 of 44 Results Clear All

Gladstone in the News September 19, 2023

The 2023 PharmaVoice 100

PharmaVoice—PharmaVoice recently assembled its annual list of inspiring leaders in the industry. Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, was named to the list as a cancer care visionary, recognized for both his scientific innovation and his dedication to collaboration and mentoring.

Gladstone Experts Genomic Immunology Marson Lab

Gladstone's Franziska Blaeschke and Stanford’s Theo Roth in the lab at Gladstone Institutes

Article September 14, 2023

Lego-Like Gene Editing Tool Lets Researchers Improve Cancer Immunotherapy

Scientists used a new method to screen 10,000 combinations of gene edits in immune cells engineered to fight cancer

News Release Research (Publication) Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing

Murad Mamedov, postdoctoral scholar at Gladstone Institutes

Article August 30, 2023

How Unique Immune Cells Can Recognize—and Destroy—Tumors

New study explains how understudied cells in the immune system, called gamma delta T cells, can target cancer cells for destruction

News Release Research (Publication) Cancer Genomic Immunology Marson Lab

Gladstone in the News April 25, 2023

New Approach to CRISPR Delivery Opens the Door to Editing Multiple Genes Safely

Innovative Genomics Institute—Work from Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and Affiliate Investigator Justin Eyquem demonstrates a new, more efficient and gentle method to introduce CRISPR editing machinery into cells.

Gladstone Experts Genomic Immunology Eyquem Lab Marson Lab CRISPR/Gene Editing

Matthew Spitzer, affiliate investigator at Gladstone Institutes

Article March 17, 2023

Can Lymph Nodes Boost the Success of Cancer Immunotherapy?

New data show therapies may activate lymph nodes to produce tumor-tackling T cells

News Release Research (Publication) Cancer Genomic Immunology Spitzer Lab

Gladstone in the News January 26, 2023

The Race to Supercharge Cancer-Fighting T Cells

Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.

Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing

Gladstone in the News December 23, 2022

Parker Institute Extends ‘Crazy Idea’ Funding to Two More Cancer Centers

STAT News—The Parker Institute for Cancer Immunotherapy has expanded to include a new center at Gladstone Institutes. Center Director Alex Marson says the funding will enable Gladstone scientists to take on bold, high-risk ideas and create better cell therapies for cancer.

Institutional News Cancer Genomic Immunology Marson Lab

Collage of images from Gladstone's top stories of 2022

Article December 9, 2022

Re-Engineering the Human Immune System

Researchers at the Gladstone-UCSF Institute of Genomic Immunology are learning how to harness the power of the human immune system in new ways

Gladstone Experts Cancer Genomic Immunology Carnevale Lab Doudna Lab Marson Lab Pelka Lab Roybal Lab Tang Lab Ye Lab

Article November 10, 2022

“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells

New Approach Analyzes How Well Different Re-Engineered T Cells Work Against Cancer

News Release Research (Publication) Cancer Genomic Immunology Roybal Lab

Gladstone in the News August 29, 2022

A Better, Faster, More Effective Way to Edit Genes

Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, comments on breakthrough technology developed in his lab that will greatly facilitate the large-scale engineering of immune cells for cell-based therapies.

Gladstone Experts Genomic Immunology Marson Lab CRISPR/Gene Editing